Literature DB >> 15194748

Tax relieves transcriptional repression by promoting histone deacetylase 1 release from the human T-cell leukemia virus type 1 long terminal repeat.

Hanxin Lu1, Cynthia A Pise-Masison, Rebecca Linton, Hyeon Ung Park, R Louis Schiltz, Vittorio Sartorelli, John N Brady.   

Abstract

Expression of human T-cell leukemia virus type 1 (HTLV-1) is regulated by the viral transcriptional activator Tax. Tax activates viral transcription through interaction with the cellular transcription factor CREB and the coactivators CBP/p300. In this study, we have analyzed the role of histone deacetylase 1 (HDAC1) on HTLV-1 gene expression from an integrated template. First we show that trichostatin A, an HDAC inhibitor, enhances Tax expression in HTLV-1-transformed cells. Second, using a cell line containing a single-copy HTLV-1 long terminal repeat, we demonstrate that overexpression of HDAC1 represses Tax transactivation. Furthermore, a chromatin immunoprecipitation assay allowed us to analyze the interaction of transcription factors, coactivators, and HDACs with the basal and activated HTLV-1 promoter. We demonstrate that HDAC1 is associated with the inactive, but not the Tax-transactivated, HTLV-1 promoter. In vitro and in vivo glutathione S-transferase-Tax pull-down and coimmunoprecipitation experiments demonstrated that there is a direct physical association between Tax and HDAC1. Importantly, biotinylated chromatin pull-down assays demonstrated that Tax inhibits and/or dissociates the binding of HDAC1 to the HTLV-1 promoter. Our results provide evidence that Tax interacts directly with HDAC1 and regulates binding of the repressor to the HTLV-1 promoter.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194748      PMCID: PMC421680          DOI: 10.1128/JVI.78.13.6735-6743.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  The NF-kappa B signaling pathway is not required for Fas ligand gene induction but mediates protection from activation-induced cell death.

Authors:  I Rivera-Walsh; M E Cvijic; G Xiao; S C Sun
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

2.  Histone deacetylases specifically down-regulate p53-dependent gene activation.

Authors:  L J Juan; W J Shia; M H Chen; W M Yang; E Seto; Y S Lin; C W Wu
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

3.  The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression.

Authors:  B P Ashburner; S D Westerheide; A S Baldwin
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

4.  Genome-wide expression changes induced by HTLV-1 Tax: evidence for MLK-3 mixed lineage kinase involvement in Tax-mediated NF-kappaB activation.

Authors:  P W Ng; H Iha; Y Iwanaga; M Bittner; Y Chen; Y Jiang; G Gooden; J M Trent; P Meltzer; K T Jeang; S L Zeichner
Journal:  Oncogene       Date:  2001-07-27       Impact factor: 9.867

5.  Duration of nuclear NF-kappaB action regulated by reversible acetylation.

Authors:  W Fischle; E Verdin; W C Greene
Journal:  Science       Date:  2001-08-31       Impact factor: 47.728

6.  Gene expression array of HTLV type 1-infected T cells: Up-regulation of transcription factors and cell cycle genes.

Authors:  C de La Fuente; L Deng; F Santiago; L Arce; L Wang; F Kashanchi
Journal:  AIDS Res Hum Retroviruses       Date:  2000-11-01       Impact factor: 2.205

7.  Induction of Tax i expression in MT-4 cells by 5-azacytidine leads to protein binding in the HTLV-1 LTR in vivo.

Authors:  S Datta; N H Kothari; H Fan
Journal:  Virology       Date:  2001-05-10       Impact factor: 3.616

8.  Human T-lymphotropic virus type I Tax protein utilizes distinct pathways for p53 inhibition that are cell type-dependent.

Authors:  C A Pise-Masison; R Mahieux; M Radonovich; H Jiang; J N Brady
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

9.  A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program.

Authors:  A Mal; M Sturniolo; R L Schiltz; M K Ghosh; M L Harter
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

Review 10.  p300/CBP proteins: HATs for transcriptional bridges and scaffolds.

Authors:  H M Chan; N B La Thangue
Journal:  J Cell Sci       Date:  2001-07       Impact factor: 5.285

View more
  26 in total

1.  Tax abolishes histone H1 repression of p300 acetyltransferase activity at the human T-cell leukemia virus type 1 promoter.

Authors:  Kasey L Konesky; Jennifer K Nyborg; Paul J Laybourn
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

Review 2.  Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation.

Authors:  Zdenko Herceg; Marie-Pierre Lambert; Karin van Veldhoven; Christiana Demetriou; Paolo Vineis; Martyn T Smith; Kurt Straif; Christopher P Wild
Journal:  Carcinogenesis       Date:  2013-06-07       Impact factor: 4.944

3.  RNA stability regulates human T cell leukemia virus type 1 gene expression in chronically-infected CD4 T cells.

Authors:  Hsin-Ching Lin; Peter J Simon; Riza M Ysla; Steven L Zeichner; Gary Brewer; Arnold B Rabson
Journal:  Virology       Date:  2017-05-04       Impact factor: 3.616

4.  Tax interacts with P-TEFb in a novel manner to stimulate human T-lymphotropic virus type 1 transcription.

Authors:  Meisheng Zhou; Hanxin Lu; Hyeon Park; Jaime Wilson-Chiru; Rebecca Linton; John N Brady
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

Review 5.  Human T cell lymphotropic virus-associated leukemia/lymphoma.

Authors:  Lee Ratner
Journal:  Curr Opin Oncol       Date:  2005-09       Impact factor: 3.645

6.  Immunostimulation by induced expression of NKG2D and its MIC ligands in HTLV-1-associated neurologic disease.

Authors:  Nazli Azimi; Steven Jacobson; Yuetsu Tanaka; Lawrence Corey; Veronika Groh; Thomas Spies
Journal:  Immunogenetics       Date:  2006-03-28       Impact factor: 2.846

7.  Suppression of viral gene expression in bovine leukemia virus-associated B-cell malignancy: interplay of epigenetic modifications leading to chromatin with a repressive histone code.

Authors:  Makram Merimi; Pavel Klener; Maud Szynal; Yvette Cleuter; Pierre Kerkhofs; Arsène Burny; Philippe Martiat; Anne Van den Broeke
Journal:  J Virol       Date:  2007-03-28       Impact factor: 5.103

8.  Effective treatment of a murine model of adult T-cell leukemia using depsipeptide and its combination with unmodified daclizumab directed toward CD25.

Authors:  Jing Chen; Meili Zhang; Wei Ju; Thomas A Waldmann
Journal:  Blood       Date:  2008-10-23       Impact factor: 22.113

9.  Imaging spontaneous tumorigenesis: inflammation precedes development of peripheral NK tumors.

Authors:  Dan Rauch; Shimon Gross; John Harding; Stefan Niewiesk; Michael Lairmore; David Piwnica-Worms; Lee Ratner
Journal:  Blood       Date:  2008-10-29       Impact factor: 22.113

10.  Modulation of the Brd4/P-TEFb interaction by the human T-lymphotropic virus type 1 tax protein.

Authors:  Won-Kyung Cho; Meisheng Zhou; Moon Kyoo Jang; Keven Huang; Soo-Jin Jeong; Keiko Ozato; John N Brady
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.